Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Minority Interest (2021 - 2026)

Nutex Health (NUTX) has disclosed Minority Interest for 6 consecutive years, with $95.8 million as the latest value for Q1 2026.

  • For Q1 2026, Minority Interest rose 22.27% year-over-year to $95.8 million; the TTM value through Mar 2026 reached $95.8 million, up 22.27%, while the annual FY2025 figure was $94.0 million, 67.56% up from the prior year.
  • Minority Interest hit $95.8 million in Q1 2026 for Nutex Health, up from $94.0 million in the prior quarter.
  • Across five years, Minority Interest topped out at $120.9 million in Q3 2025 and bottomed at $194747.0 in Q1 2022.
  • Average Minority Interest over 5 years is $43.1 million, with a median of $22.0 million recorded in 2022.
  • On a YoY basis, Minority Interest climbed as much as 35179.88% in 2022 and fell as far as 68.2% in 2022.
  • Nutex Health's Minority Interest stood at $24.5 million in 2022, then decreased by 27.84% to $17.7 million in 2023, then skyrocketed by 217.76% to $56.1 million in 2024, then surged by 67.56% to $94.0 million in 2025, then increased by 1.88% to $95.8 million in 2026.
  • According to Business Quant data, Minority Interest over the past three periods came in at $95.8 million, $94.0 million, and $120.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.